2021 annual financial data
Autolus Therapeutics 2021 Operating margin
Direct answer
Operating margin was -9,314.8%.
Operating income was -140,374,000 USD and net income was -142,096,000 USD.
Operating cash flow was -117,861,000 USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,507,000 USD
- Operating income
- -140,374,000 USD
- Net income
- -142,096,000 USD
- Operating cash flow
- -117,861,000 USD